Antithrombotic agents Flashcards

1
Q

What are the different types of antithrombotic agents

A
  • Anticoagulants (inhibit 1+ components of coag cascade),
  • Fibrinolytic agents (enhance lysis of clot),
  • Anti-platelet agents (inhibit platelet activation or aggregation via platelet receptor inhibition or platelet signalling pathway inhibition)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name the different types of anticoagulants and their main mechanism of action

A
  • Heparin and fondaparinux. Act via antithombin and antagonising factor Xa.
  • Oral warfarin - Vitamin K antagonist so lowers factors II, VII, IX and X,
  • Direct oral anticoagulants which mainly act as Xa inhibitors except dabigatran which is a IIa inhibitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In more detail describe the mechanism of action of heparins

A
  • Augment activity of endogenous antithrombin (particularly anti IIa and Xa activity).
  • Does not cross placenta so can be used in pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the differences between unfractionated heparin and low molecular weight heparin

A

LMWH has a safer side effect profile, requires 1 injection a day, higher bioavailabilty, requires no monitoring and can be used in out-patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the indications for hepatin

A
  • Provides immediate short acting anticoagulant effect. so can be used in:
  • Acute DVT/PE,
  • During cardiac bypass surgery (UFH),
  • Acute coronary syndromes,
  • Post VTE in cancer patients,
  • Prophylaxis of VTE in post op patients and in obstetrics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the mechanism of warfarin and some of its main features

A
  • Inhibits the vitamin K oxide reductase. Important because the process of oxidisation of vitamin K is used in the production of prothrombin.
  • It has a narrow theraputic window so require regular INR monitoring. It also has many drug and food interactions
  • Long onset and off-set so not good for short term use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the indications for use of warfarin?

A
  • Atrial fibrillation (it can reduce the risk of stroke)
  • In acute DVT or PE as it reduces risk of recurrent/fatal PEs
  • Prosthetic heart valve
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the benefits of DOACs as apposed to warfarin?

A
  • Rapid onset and offser
  • Only requires an annual review,
  • Few drug/food interactions,
  • Minor side effects whereas warfarin may increase risk of bleed, lower risk of IC haemorrhage.
  • Reversal agents are being developed however it is easy to reverse warfarin by vitamin K
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Name some examples of DOACs

A

Factor IIa inhibitor - Dabigatran
Factor Xa inhibitors - Rivaroxaban, apixaban, edoxaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the reversal agent for dabigatran?

A

Idarucizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the major fibrinolytic drug classes and some examples and their uses

A
  • Kinases (streptokinase and urokinase) Older drugs
  • Tissue plasminogen activators (alteplase, tenecteplase, reteplase)
  • Used to breakdown a pathological thrombus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the mechanism of action of kinases and their limitations

A
  • Bind to plasminogen to release plasmin and enhance the breakdown of fibrin.
  • However they work on free plasminogen in the blood as well as clot bound. So can cause systemic fibrinolysis and increase risk of bleeds.
  • Streptokinase is derived from streptococci bacteria so if previous strep infection/use of streptokinase then immune response can render drug ineffective.
  • Urokinase is a cellular derivative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the mechanism of action of clopidogrel and ticlopidine

A

They irreversibly block the ADP receptor of platelets which decreases the expression of GPIIb/IIIa and reduced binding of fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name and describe the mechanism of action of GPIIb/IIIa antagonists

A

Abciximab and tirofiban. They are monoclonal antibodies that antagonise the glycoprotein IIb and IIIa receptors which reduce platelet aggregation and reduce binding of fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the mechanism of action of aspirin

A
  • Irreversible inhibition of cyclooxygenase which blocks the conversion of arachidonic acid into thromboxane A2, reducing platelet activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Name a phosphodiesterase III inhibitor and its mechanism of action

A

Dipyridamole. It increases platelet concentration of cAMP which leads to reduced platelet responsiveness to ADP and reduced platelet aggregation.

17
Q

Name a thromboxane synthetase inhibitor and a thromboxane receptor blcoked

A
  • Picotamide (combined mechanism of action)
  • Ifetroban (receptor blocker) - not licenced in the UK
18
Q

What is the indications for an antiplatelet drugs

A
  • Cardiovascular disease,
  • Acute MI (Aspirin indefinitely, clopidogrel/ticagrelor for up to 12 months +/- tirofiban acutely)
  • Secondary prevention of CVD (Aspirin)
  • Cerebrovascular disease (without AF),
  • Acute stroke/TIA/secondary prevention (Clopidogrel or aspirin and dipyridamole if clopidogrel is not tolerated),
  • Peripheral vascular disease (Clopidogrel or aspirin if not tolerated)